FEMASYS INC (FEMY) Stock News

NASDAQ:FEMY - Nasdaq - US31447E1055 - Common Stock - Currency: USD

0.9 -0.02 (-1.66%)

After market: 0.918 +0.02 (+2%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FEMY Latest News, Press Relases and Analysis

All

Press Releases

25 days ago - By: Femasys Inc.

Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic

25 days ago - By: Femasys Inc.

Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic

a month ago - By: Femasys Inc.

Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control

a month ago - By: Femasys Inc.

Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control

a month ago - By: Benzinga

The Analyst Verdict: Femasys In The Eyes Of 6 Experts

3 months ago - By: Benzinga

Analyst Expectations For Femasys's Future

a month ago - By: Femasys Inc.

Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth

a month ago - By: Femasys Inc.

Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations

a month ago - By: Femasys Inc.

Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations

2 months ago - By: Femasys Inc.

Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million

2 months ago - By: Femasys Inc.

Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million

2 months ago - By: Femasys Inc.

Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

2 months ago - By: Femasys Inc.

Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

3 months ago - By: Zacks Investment Research - Mentions: LXRX

Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates

3 months ago - By: Femasys Inc.

Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update

3 months ago - By: Femasys Inc.

Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update

3 months ago - By: Zacks Investment Research - Mentions: CRIS

Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: BMRN

BioMarin Pharmaceutical (BMRN) Beats Q1 Earnings and Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: BMRN

Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates

4 months ago - By: Femasys Inc.

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

4 months ago - By: Femasys Inc.

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

4 months ago - By: Femasys Inc.

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

4 months ago - By: Femasys Inc.

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

4 months ago - By: ACCESS Newswire - Mentions: DRTS GIFT VOXR ZCAR ...

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

4 months ago - By: Femasys Inc.

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

4 months ago - By: Femasys Inc.

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

4 months ago - By: Femasys Inc.

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

4 months ago - By: Femasys Inc.

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

5 months ago - By: Femasys Inc.

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

5 months ago - By: Femasys Inc.

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

5 months ago - By: Femasys Inc.

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

5 months ago - By: Femasys Inc.

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices